Literature DB >> 8897231

Enzymes protective of oxidative damage present in all decades of life in the trabecular meshwork, as detected by two-dimensional gel electrophoresis protein maps.

P Russell1, D H Johnson.   

Abstract

Our purpose was to determine whether there are age-related differences in the presence of enzymes protective against oxidative damage in normal human trabecular meshwork (TM). The study was also done to determine whether there are significant changes in proteins related to age, gender, or position around the circumference of the meshwork. Human TM was dissected from both eyes of 16 normal donors ranging in age from 9 to 91 years. Proteins were mapped with two-dimensional (2D) gel electrophoresis. The microanalytical method used allowed analysis of samples as small as one fourth of a single meshwork. Selected proteins were identified by Western blot. Superoxide dismutase (SOD) and glutathione reductase were present in all ages on the 2D maps. Age-related changes in the TM were not apparent, although slight differences may exist between juvenile and adult TM, since differences in the relative intensities of some polypeptides were evident. In any single quadrant of the TM, > or = 160 protein spots could be counted visually. The 2D maps of the various quadrants were very similar, and the protein patterns were analogous between fellow eyes. Distinct differences were noted between maps from TM and adjacent cornea and sclera. Other protein spots identified included actin, albumin, transferrin, and vimentin. The TM samples had a mean cellular protein content of 66.3 +/- 15.4 micrograms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897231

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  10 in total

1.  Individual molecular response to elevated intraocular pressure in perfused postmortem human eyes.

Authors:  Núria Comes; Teresa Borrás
Journal:  Physiol Genomics       Date:  2009-04-28       Impact factor: 3.107

Review 2.  Focus on molecular events in the anterior chamber leading to glaucoma.

Authors:  Sergio Claudio Saccà; Alberto Izzotti
Journal:  Cell Mol Life Sci       Date:  2013-10-19       Impact factor: 9.261

Review 3.  The many faces of the trabecular meshwork cell.

Authors:  W Daniel Stamer; Abbot F Clark
Journal:  Exp Eye Res       Date:  2016-07-19       Impact factor: 3.467

Review 4.  Stress response of the trabecular meshwork.

Authors:  Paloma B Liton; Pedro Gonzalez
Journal:  J Glaucoma       Date:  2008-08       Impact factor: 2.503

5.  Effect of PITX2 knockdown on transcriptome of primary human trabecular meshwork cell cultures.

Authors:  Seyed Hassan Paylakhi; Jian-Bing Fan; Mohadeseh Mehrabian; Majid Sadeghizadeh; Shahin Yazdani; Ali Katanforoush; Mozhgan Rezaei Kanavi; Mostafa Ronaghi; Elahe Elahi
Journal:  Mol Vis       Date:  2011-05-05       Impact factor: 2.367

Review 6.  Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma.

Authors:  A K Cybulska-Heinrich; M Mozaffarieh; J Flammer
Journal:  Mol Vis       Date:  2012-02-09       Impact factor: 2.367

Review 7.  Oxygen and blood flow: players in the pathogenesis of glaucoma.

Authors:  Maneli Mozaffarieh; Matthias C Grieshaber; Josef Flammer
Journal:  Mol Vis       Date:  2008-01-31       Impact factor: 2.367

8.  A Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA Sequencing.

Authors:  Jaclyn Y Bermudez; Hannah C Webber; Bartley Brown; Terry A Braun; Abbot F Clark; Weiming Mao
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

Review 9.  The Eye, Oxidative Damage and Polyunsaturated Fatty Acids.

Authors:  Sergio Claudio Saccà; Carlo Alberto Cutolo; Daniele Ferrari; Paolo Corazza; Carlo Enrico Traverso
Journal:  Nutrients       Date:  2018-05-24       Impact factor: 5.717

10.  Protein expression in human trabecular meshwork: downregulation of RhoGDI by dexamethasone in vitro.

Authors:  Minbin Yu; Jing Sun; Wei Peng; Ziyan Chen; Xianchai Lin; Xuyang Liu; Mingtao Li; Kaili Wu
Journal:  Mol Vis       Date:  2010-02-13       Impact factor: 2.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.